“…Serum zinc levels are increased in melanoma patients (Ros-Bullon et al, 1998) but more often, reduced serum zinc levels are reported in breast (Sharma et al, 1994;Yucel et al, 1994), gallbladder (Gupta et al, 2005), lung (Diez et al, 1989;Issell et al, 1981), Hodgkin's disease (Cunzhi et al, 2001), colorectal (Gupta et al, 1993), neck (Buntzel et al, 2007), leukemia (Zuo et al, 2006) and thyroid (Al-Sayer et al, 2004) cancer patients. Elevated zinc levels in malignant tissues are observed in breast (Margalioth et al, 1983), intestinal (Kucharzewski et al, 2003), metastatic nasopharyngeal (Bay et al, 1997) cancers but are decreased in kidney carcinoma tissues (Margalioth et al, 1983). It is also high in bone marrow of patients with non-Hodgkin lymphomas (Schmitt et al, 1993).…”